Evidence library
Bone Loss After Menopause: The Symptom You Cannot Feel
Most menopause symptoms announce themselves. Bone loss does not. It progresses quietly for years, which is why it is often identified only after a fracture.
What the research shows
Estrogen plays a direct role in maintaining bone density, and its decline at menopause is associated with accelerated bone loss and increased fracture risk. Estrogen therapy for the prevention of postmenopausal bone loss is one of the most established indications in menopause medicine.
What this means for you
Bone health belongs in the conversation early, alongside the symptoms that brought you in. It is also one of the areas where hormone therapy, nutrition, and resistance training genuinely reinforce one another.
Important context
Bone health decisions should account for your fracture risk, bone density testing where appropriate, and your full medical history. Hormone therapy is one option among several, and the right approach is individual. Individual results vary.
Schedule a free discovery call
References
- Levin VA, et al.. Estrogen therapy for osteoporosis in the modern era. Osteoporosis International. 2018;29:1049-1055. Evidence A
Common questions
- When should I start thinking about bone health?
- Earlier than most people expect. Bone loss accelerates around the menopause transition, so it belongs in the conversation alongside the symptoms that brought you in rather than years later.
- Does hormone therapy replace other bone health measures?
- No. Nutrition, resistance training, and appropriate screening remain part of the picture. These approaches reinforce one another rather than substitute for one another.